Pfizer (PFE) Raises Quarterly Dividend 5.9% to $0.36, 3.3% Yield; Authorizes New $10B Buyback
- S&P 500 and Nasdaq notch highest closes since early 2022
- U.S. economy adds 199,000 jobs in November
- Fed should 'lowball' rate cuts expectations next week says analyst after strong jobs data
- Bernstein's best idea for 2024? Short Tesla stock
- Analysts defend Broadcom as annual guidance falls short after FQ4 earnings beat
(Updated - December 14, 2018 12:14 PM EST)
Pfizer (NYSE: PFE) declared a quarterly dividend of $0.36 per share, or $1.44 annualized. This is a 5.9% increase from the prior dividend of $0.34.
The dividend will be payable on March 1, 2019, to stockholders of record on February 1, 2019, with an ex-dividend date of January 31, 2019.
The annual yield on the dividend is 3.3 percent.
“We are confident in the business and focused on maximizing total shareholder return, of which the dividend remains a key component,” stated Ian Read, Pfizer chairman and chief executive officer.
New Buyback Plan
Keeping with past practice, the board of directors also authorized a new $10 billion share repurchase program to be utilized over time. This new program is in addition to the $4.9 billion remaining under the company’s current authorization.
For a dividend history and other dividend-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Albany International (AIN) Raises Quarterly Dividend 4% to $0.26; 1.2% Yield
- U-Haul Holding (UHAL) Raises Quarterly Dividend 25% to $0.05; 0.3% Yield
- Marriott Vacations Worldwide (VAC) Raises Quarterly Dividend 5.6% to $0.76; 3.9% Yield
Create E-mail Alert Related CategoriesDividend Hike, Dividends, Hot Buybacks, Management Comments, Stock Buybacks
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!